Literature DB >> 27864881

Visual system manifestations of Alzheimer's disease.

Yael Kusne1, Andrew B Wolf2, Kate Townley1, Mandi Conway1,3, Gholam A Peyman1,3.   

Abstract

Alzheimer's disease (AD) is an increasingly common disease with massive personal and economic costs. While it has long been known that AD impacts the visual system, there has recently been an increased focus on understanding both pathophysiological mechanisms that may be shared between the eye and brain and how related biomarkers could be useful for AD diagnosis. Here, were review pertinent cellular and molecular mechanisms of AD pathophysiology, the presence of AD pathology in the visual system, associated functional changes, and potential development of diagnostic tools based on the visual system. Additionally, we discuss links between AD and visual disorders, including possible pathophysiological mechanisms and their relevance for improving our understanding of AD.
© 2016 Acta Ophthalmologica Scandinavica Foundation. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Alzheimer's disease; amyloid; biomarkers; neurodegeneration; ocular; retina; tau; visual; visual system

Mesh:

Year:  2016        PMID: 27864881     DOI: 10.1111/aos.13319

Source DB:  PubMed          Journal:  Acta Ophthalmol        ISSN: 1755-375X            Impact factor:   3.761


  13 in total

1.  Pilot Study: The Queen Square Screening Test for Visual Deficits in Dementia.

Authors:  Leah N Kim; Dennis Cordato; Alan McDougall; Clare Fraser
Journal:  Neuroophthalmology       Date:  2021-08-11

2.  Relation of retinal and hippocampal thickness in patients with amnestic mild cognitive impairment and healthy controls.

Authors:  Markus Donix; Dierk Wittig; Wiebke Hermann; Robert Haussmann; Maren Dittmer; Franziska Bienert; Maria Buthut; Liane Jacobi; Annett Werner; Jennifer Linn; Tjalf Ziemssen; Moritz D Brandt
Journal:  Brain Behav       Date:  2021-01-15       Impact factor: 2.708

3.  Mesenchymal stem cell-conditioned medium attenuates the retinal pathology in amyloid-β-induced rat model of Alzheimer's disease: Underlying mechanisms.

Authors:  Shu-Chun Kuo; Chung-Ching Chio; Chao-Hung Yeh; Jui-Ti Ma; Wen-Pin Liu; Mao-Tsun Lin; Kao-Chang Lin; Ching-Ping Chang
Journal:  Aging Cell       Date:  2021-03-30       Impact factor: 9.304

Review 4.  Visual Features in Alzheimer's Disease: From Basic Mechanisms to Clinical Overview.

Authors:  María Alejandra Cerquera-Jaramillo; Mauricio O Nava-Mesa; Rodrigo E González-Reyes; Carlos Tellez-Conti; Alejandra de-la-Torre
Journal:  Neural Plast       Date:  2018-10-14       Impact factor: 3.599

5.  Human Tau Expression Does Not Induce Mouse Retina Neurodegeneration, Suggesting Differential Toxicity of Tau in Brain vs. Retinal Neurons.

Authors:  Léa Rodriguez; Julius Baya Mdzomba; Sandrine Joly; Mélissa Boudreau-Laprise; Emmanuel Planel; Vincent Pernet
Journal:  Front Mol Neurosci       Date:  2018-08-24       Impact factor: 5.639

Review 6.  Strengths and Weaknesses of the Gray Mouse Lemur (Microcebus murinus) as a Model for the Behavioral and Psychological Symptoms and Neuropsychiatric Symptoms of Dementia.

Authors:  Fabien Pifferi; Jacques Epelbaum; Fabienne Aujard
Journal:  Front Pharmacol       Date:  2019-10-30       Impact factor: 5.810

7.  Combination of snapshot hyperspectral retinal imaging and optical coherence tomography to identify Alzheimer's disease patients.

Authors:  Sophie Lemmens; Toon Van Craenendonck; Jan Van Eijgen; Lies De Groef; Rose Bruffaerts; Danilo Andrade de Jesus; Wouter Charle; Murali Jayapala; Gordana Sunaric-Mégevand; Arnout Standaert; Jan Theunis; Karel Van Keer; Mathieu Vandenbulcke; Lieve Moons; Rik Vandenberghe; Patrick De Boever; Ingeborg Stalmans
Journal:  Alzheimers Res Ther       Date:  2020-11-10       Impact factor: 6.982

8.  Afferent and Efferent Visual Markers of Alzheimer's Disease: A Review and Update in Early Stage Disease.

Authors:  Shirley Z Wu; Arjun V Masurkar; Laura J Balcer
Journal:  Front Aging Neurosci       Date:  2020-09-11       Impact factor: 5.750

9.  Altered Frequency-Dependent Brain Activation and White Matter Integrity Associated With Cognition in Characterizing Preclinical Alzheimer's Disease Stages.

Authors:  Siyu Wang; Jiang Rao; Yingying Yue; Chen Xue; Guanjie Hu; Wenzhang Qi; Wenying Ma; Honglin Ge; Fuquan Zhang; Xiangrong Zhang; Jiu Chen
Journal:  Front Hum Neurosci       Date:  2021-02-16       Impact factor: 3.169

10.  Pathogenesis of sporadic Alzheimer's disease by deficiency of NMDA receptor subunit GluN3A.

Authors:  Weiwei Zhong; Anika Wu; Ken Berglund; Xiaohuan Gu; Michael Qize Jiang; Jay Talati; Jingjie Zhao; Ling Wei; Shan Ping Yu
Journal:  Alzheimers Dement       Date:  2021-06-20       Impact factor: 21.566

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.